☆ 4.4 Letter

MK2 is a therapeutic target for high-risk multiple myeloma

HAEMATOLOGICA (2021)

Get Full Text
Add to Collection

Journal

HAEMATOLOGICA
Volume 106, Issue 6, Pages 1774-1777

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2017.182121

Keywords

-

Categories

Hematology

Funding

  1. National Natural Science Foundation of China [81770220, 81600177, 81670200, 81500166]
  2. National key research and development programprecision medicine subprogram [2016YFC0905900]
  3. 2016 outstanding youth fund of Jiangsu Province [BK20160048]
  4. Natural Science Foundation of Jiangsu Province [BK20161041, 16KJB310009]
  5. Priority Academic Program Development of Jiangsu Higher Education Institutions for Chinese Medicine

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.